Cosmetic Research Analysis
March’s cosmetic medicine literature converged on translational biomaterials, function-first reconstruction, and evidence-driven diagnostics for cosmetically sensitive disease. A randomized multicenter phase II trial showed a tissue-engineered autologous dermo-epidermal graft (denovoSkin) improved scar quality versus split-thickness grafts, while a tri-functional injectable bioadhesive accelerated closure of infected wounds in preclinical models. Microneedle delivery of recombinant Filaggrin-2 r
Summary
March’s cosmetic medicine literature converged on translational biomaterials, function-first reconstruction, and evidence-driven diagnostics for cosmetically sensitive disease. A randomized multicenter phase II trial showed a tissue-engineered autologous dermo-epidermal graft (denovoSkin) improved scar quality versus split-thickness grafts, while a tri-functional injectable bioadhesive accelerated closure of infected wounds in preclinical models. Microneedle delivery of recombinant Filaggrin-2 reversed dermal papilla mitochondrial dysfunction and promoted hair growth in androgenetic alopecia models. An international consensus standardized dermoscopy/RCM-led mapping and management of lentigo maligna. Across the month, chemical safety surveillance (PFAS/heavy metals) and noninvasive analytical tools continued to inform safer cosmetic practice.
Selected Articles
1. Safety and efficacy of bio-engineered, autologous dermo-epidermal skin grafts in reconstructive surgery: 1-year results of a prospective, randomized, intra-patient controlled, multicenter phase II clinical trial.
In a multicenter phase II randomized intra-patient controlled trial (n=23), denovoSkin™, an autologous bio-engineered dermo-epidermal graft, achieved significantly better observer-rated scar quality at 3 months compared with paired split-thickness grafts, with feasibility and safety demonstrated over 1 year.
Impact: Provides randomized, intra-patient controlled evidence that a tissue-engineered autologous skin substitute can improve scar outcomes and reduce donor-site morbidity versus standard grafting.
Clinical Implications: DenovoSkin may be considered as an alternative to STSG in full-thickness defects and burn reconstruction pending phase III confirmation, informing reconstructive planning and patient counseling about scar quality and donor-site trade-offs.
Key Findings
- Randomized intra-patient controlled multicenter phase II design with paired denovoSkin and STSG sites.
- Observer-rated POSAS total score at 3 months favored denovoSkin (23.4) over STSG (27.9).
- Feasibility and safety demonstrated over 1-year follow-up.
2. Functional Reconstruction of Abdominal Wall in Prune Belly Syndrome Using Vastus Lateralis Muscle Flaps: A Prospective Observational Study.
A prospective series using bilateral pedicled, innervated vastus lateralis musculo-fascial flaps recreated rectus abdominis vectors in Prune Belly Syndrome; EMG and motor testing confirmed active contraction, improved core function, and symptom reduction related to low intra-abdominal pressure.
Impact: First reproducible dynamic reanimation of the anterior abdominal wall in this rare disorder with objective functional endpoints—shifting reconstructive goals from contour to physiology.
Clinical Implications: Offers a function-first surgical option potentially restoring cough, defecation, and posture; requires multidisciplinary planning, donor-site risk mitigation, and standardized rehabilitation.
Key Findings
- Bilateral pedicled, innervated vastus lateralis flaps recreated rectus abdominis functional vectors enabling dynamic contraction.
- EMG and motor testing confirmed active contraction with improved core function.
- Symptoms linked to inadequate intra-abdominal pressure (e.g., constipation, respiratory infections) decreased postoperatively.
3. Recombinant Filaggrin-2 microneedles reverse androgenetic alopecia by rescuing mitochondrial dysfunction in dermal papilla cells.
Preclinical studies show DHT downregulates FLG2 in dermal papilla cells; hyaluronic acid microneedles delivering recombinant FLG2 restored DPC viability and mitochondrial function, prolonged anagen, and increased follicle density in mouse AGA models.
Impact: Identifies FLG2 as a novel, mechanism-based target for AGA and demonstrates minimally invasive biologic delivery with in vivo efficacy.
Clinical Implications: Pending human safety and immunogenicity, rFLG2 microneedles could offer a targeted topical therapy addressing mitochondrial dysfunction in dermal papilla cells; dose-finding and early human trials are warranted.
Key Findings
- DHT downregulates FLG2 in dermal papilla cells, contributing to AGA pathogenesis.
- rFLG2 microneedles restored DPC viability, migration, and adhesion via MAPK/Erk activation and Bcl-2/Bax rebalancing.
- In AGA mouse models, rFLG2 microneedles prolonged anagen and increased follicle density; also accelerated wound healing.
4. An Injectable CMCS/γ-PGA/PRP Bioadhesive With Antibacterial, Adhesive, and Regenerative Properties for Infected Wound Healing.
An injectable bioadhesive (CγR) combining carboxymethyl chitosan, γ‑polyglutamic acid, and autologous PRP achieved >99.9% bactericidal activity, rapid wet‑tissue adhesion, sustained growth factor release, and sterile sealing with complete epithelialization by day 6 in infected rat wounds.
Impact: Condenses suture, antibiotic, and dressing functions into a scalable platform integrating antimicrobial and regenerative signaling—promising for contaminated wounds in aesthetic/reconstructive practice.
Clinical Implications: If translated to humans, this one-step bioadhesive could reduce infection rates and accelerate closure in contaminated traumatic or surgical wounds; human toxicology and randomized trials are needed.
Key Findings
-
99.9% bactericidal efficacy against E. coli and S. aureus with instantaneous wet‑tissue adhesion >3 kPa.
- In infected rat full‑thickness wounds, single application achieved sterile sealing and complete epithelialization within 6 days.
- Sustained release of PDGF/TGF‑β/VEGF supported collagen deposition and M2 macrophage polarization.
5. International Dermoscopy Society consensus recommendations for the management of lentigo maligna.
An international multidisciplinary consensus provides practical recommendations for diagnosing, treating, and monitoring lentigo maligna on cosmetically sensitive sites, emphasizing dermoscopy/RCM mapping, multiple partial biopsies, margin-controlled excision when feasible, and topical or radiotherapy alternatives with structured imaging follow-up.
Impact: Harmonizes heterogeneous evidence into actionable guidance for a diagnostically challenging lesion on visible sites, likely reducing practice variability while protecting cosmesis and oncologic safety.
Clinical Implications: Integrate dermoscopy/RCM for lesion mapping and biopsy planning; prefer margin-controlled excision for ill-defined lesions; use topical or radiotherapy alternatives with close imaging follow-up when surgery is unsuitable.
Key Findings
- Noninvasive imaging (dermoscopy/RCM) improves diagnosis, biopsy orientation, and monitoring.
- Multiple partial biopsies increase diagnostic certainty and help exclude invasion.
- Margin-controlled excision is preferred for large or poorly defined lesions; imiquimod or radiotherapy are alternatives when surgery is unsuitable.